MK-2866 CAS:841205-47-8

Enobosarm, better known as Ostarine or MK 2866, is a Selective Androgen Receptor Modulator (SARM) developed by GTx (GTx-024) to combat muscle wasting and osteoporosis.

Many speculate Ostarine may find uses in hormone replacement treatment plans, as well as in the treatment of sarcopenia, cachexia and muscle atrophy. This is a highly valuable benefit to those suffering from muscle wasting diseases, more so because SARM’s have been shown to not have an impact on non-skeletal muscle.

Ostarine is arguably the most controversial SARM on the market today. It’s controversial because it was the first SARM to be the subject of a lawsuit – one Ostarine retailer was sued by its competitor for marketing Ostarine supplements as nutritional supplements when they should probably be marketed as “drugs” and be under the jurisdiction of the FDA.

Functions of Enobosarm Ostarine MK-2866

Lean Muscle Gains (Bulking)

Ostarine is the most anabolic of any SARMS, making its first and foremost use for wanting to gain lean muscle. The gains in total weight will not be comparable to bulking steroids, however the total gains will almost entirely be lean muscle.

Losing Bodyfat (Cutting)

Ostarine would primarily fit into a cutting protocol for the maintenance of muscle mass while reducing calories. One of the most disheartening outcomes of cutting is the loss hard earned muscle mass. The drop in metabolic rate and hormone levels (T3, IGF, Testosterone etc) with the lack of calories is a perfect catabolic environment for loss of muscle tissue.

Injury Prevention

The effects of ostarine translate to anabolism in bone and skeletal muscle tissue, which means it could be used in the future for a variety of uses, such as osteoporosis and as a concurrent treatment with drugs that reduce bone density. Therefore it has great application as a compound to use for rehabilitation of injuries, in particular bone and tendon related injuries.